Search Results - "Delmas, D."

Bone Quality — The Material and Structural Basis of Bone Strength and Fragility by Seeman, Ego, Delmas, Pierre D

“…This review discusses advances in knowledge regarding the composition and structure of bone, the modeling and remodeling of bone, the formation of bone during…”
Get full text

European guidance for the diagnosis and management of osteoporosis in postmenopausal women by Kanis, J. A, Burlet, N, Cooper, C, Delmas, P. D, Reginster, J.-Y, Borgstrom, F, Rizzoli, R

“…Summary Guidance is provided in a European setting on the assessment and treatment of postmenopausal women with or at risk from osteoporosis. Introduction The…”
Get full text

Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe by Delmas, D, Solary, E, Latruffe, N

“…Cancers are the largest cause of mortality and morbidity in industrialized countries. In the field of the medicinal chemistry of natural products, numerous…”
Get more information

The path to sustainable energy supply systems: Proposal of an integrative sustainability assessment framework by Buchmayr, A., Verhofstadt, E., Van Ootegem, L., Sanjuan Delmás, D., Thomassen, G., Dewulf, J.

“…Energy supply is essential for the functioning and well-being of a society. Decision-makers are faced with the challenge to balance burdens and benefits of…”
Get full text

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis by Szulc, P., Delmas, P. D.

“…Introduction The aim was to analyse data on the use of biochemical bone turnover markers (BTM) in postmenopausal osteoporosis. Methods We carried out a…”
Get full text

The role of collagen in bone strength by VIGUET-CARRIN, S, GARNERO, P, DELMAS, P. D

“…Bone is a complex tissue of which the principal function is to resist mechanical forces and fractures. Bone strength depends not only on the quantity of bone…”
Get full text

Alterations of Cortical and Trabecular Architecture Are Associated With Fractures in Postmenopausal Women, Partially Independent of Decreased BMD Measured by DXA: The OFELY Study by Sornay‐Rendu, Elisabeth, Boutroy, Stéphanie, Munoz, Françoise, Delmas, Pierre D

“…We assessed the role of low aBMD and impaired architecture—assessed by an HR‐pQCT system—in a case‐control study of postmenopausal women with fractures…”
Get full text

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis by Black, Dennis M, Delmas, Pierre D, Eastell, Richard, Reid, Ian R, Boonen, Steven, Cauley, Jane A, Cosman, Felicia, Lakatos, Péter, Leung, Ping Chung, Man, Zulema, Mautalen, Carlos, Mesenbrink, Peter, Hu, Huilin, Caminis, John, Tong, Karen, Rosario-Jansen, Theresa, Krasnow, Joel, Hue, Trisha F, Sellmeyer, Deborah, Eriksen, Erik Fink, Cummings, Steven R

“…In this double-blind, placebo-controlled trial, women with postmenopausal osteoporosis received an infusion of either zoledronic acid (5 mg) or placebo at…”
Get full text

Mineral maturity and crystallinity index are distinct characteristics of bone mineral by Farlay, Delphine, Panczer, Gérard, Rey, Christian, Delmas, Pierre D, Boivin, Georges

“…The purpose of this study was to test the hypothesis that mineral maturity and crystallinity index are two different characteristics of bone mineral. To this…”
Get full text

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis by Chesnut, Charles H, Skag, Arne, Christiansen, Claus, Recker, Robert, Stakkestad, Jacob A, Hoiseth, Arne, Felsenberg, Dieter, Huss, Hermann, Gilbride, Jennifer, Schimmer, Ralph C, Delmas, Pierre D

“…Oral daily (2.5 mg) and intermittent ibandronate (between‐dose interval of >2 months), delivering a similar cumulative exposure, were evaluated in 2946…”
Get full text

Environmental assessment of copper production in Europe: an LCA case study from Sweden conducted using two conventional software-database setups by Sanjuan-Delmás, D., Alvarenga, R. A. F., Lindblom, M., Kampmann, T. C., van Oers, Lauran, Guinée, Jeroen B., Dewulf, J.

“…Purpose This study focuses on the environmental assessment of European copper production. Life cycle assessment is applied to analyse copper cathode production…”
Get full text

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate by Seeman, Ego, Delmas, Pierre D, Hanley, David A, Sellmeyer, Deborah, Cheung, Angela M, Shane, Elizabeth, Kearns, Ann, Thomas, Thierry, Boyd, Steven K, Boutroy, Stephanie, Bogado, Cesar, Majumdar, Sharmila, Fan, Michelle, Libanati, Cesar, Zanchetta, Jose

“…The intensity of bone remodeling is a critical determinant of the decay of cortical and trabecular microstructure after menopause. Denosumab suppresses…”
Get full text

Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease by Chavassieux, P, Seeman, E, Delmas, P. D

“…Minimal trauma fractures in bone diseases are the result of bone fragility. Rather than considering bone fragility as being the result of a reduced amount of…”
Get full text

Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study by Sornay‐Rendu, Elisabeth, Munoz, Françoise, Garnero, Patrick, Duboeuf, François, Delmas, Pierre D

“…About one‐half of women with incident fractures have BMD above the WHO diagnostic threshold of osteoporosis. In the OFELY study, low BMD, increased markers of…”
Get full text

Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study by Delmas, Pierre D, van de Langerijt, Lex, Watts, Nelson B, Eastell, Richard, Genant, Harry, Grauer, Andreas, Cahall, David L

“…Accurate radiographic diagnosis of vertebral fractures is important. This multicenter, multinational study assessed radiographic diagnoses of vertebral…”
Get full text

The Effects of Tibolone in Older Postmenopausal Women by Cummings, Steven R, Ettinger, Bruce, Delmas, Pierre D, Kenemans, Peter, Stathopoulos, Victoria, Verweij, Pierre, Mol-Arts, Mirjam, Kloosterboer, Lenus, Mosca, Lori, Christiansen, Claus, Bilezikian, John, Kerzberg, Eduardo Mario, Johnson, Susan, Zanchetta, Jose, Grobbee, Diederich E, Seifert, Wilfried, Eastell, Richard

“…In this trial, tibolone, which has estrogenic, progestogenic, and androgenic effects, was compared with placebo in women between 60 and 85 who had osteoporosis…”
Get full text

Cross‐sectional analysis of the association between fragility fractures and bone microarchitecture in older men: The STRAMBO study by Szulc, Pawel, Boutroy, Stéphanie, Vilayphiou, Nicolas, Chaitou, Ali, Delmas, Pierre D, Chapurlat, Roland

“…Areal bone mineral density (aBMD) measured by dual‐energy X‐ray absorptiometry (DXA) identifies 20% of men who will sustain fragility fractures. Thus we need…”
Get full text

Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy by Delmas, Pierre D, Seeman, Ego

“…The structural basis for the reduction in vertebral and nonvertebral fracture risk in patients using anti-resorptive therapy is not well understood. As reduced…”
Get full text

Finite Element Analysis Based on In Vivo HR‐pQCT Images of the Distal Radius Is Associated With Wrist Fracture in Postmenopausal Women by Boutroy, Stephanie, Van Rietbergen, Bert, Sornay‐Rendu, Elisabeth, Munoz, Francoise, Bouxsein, Mary L, Delmas, Pierre D

“…BMD, bone microarchitecture, and bone mechanical properties assessed in vivo by finite element analysis were associated with wrist fracture in postmenopausal…”
Get full text

Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure by Recker, Robert R, Delmas, Pierre D, Halse, Johan, Reid, Ian R, Boonen, Steven, García‐Hernandez, Pedro A, Supronik, Jerzy, Lewiecki, E Michael, Ochoa, Luis, Miller, Paul, Hu, Huilin, Mesenbrink, Peter, Hartl, Florian, Gasser, Juerg, Eriksen, Erik F

“…In a substudy of the HORIZON pivotal fracture trial, in which yearly intravenous zoledronic acid 5 mg was found to significantly reduce risk of various…”
Get full text